Both clinics target accessible entry-level peptide access. MadeMed wins on Sermorelin price (oral $99/mo, no labs) and format diversity. Limitless Alt Med wins on BPC-157, PT-141, TRT, free consults, and published pricing.
| MadeMed | Limitless Alt Med | |
|---|---|---|
| Oral Sermorelin | $99/mo (no labs) | Not offered |
| Injectable Sermorelin | $129/mo (labs required) | $194 (no labs required) |
| BPC-157 | Not offered | $325 injectable |
| PT-141 | Not offered | $184 |
| GHK-Cu | Not offered | Yes — blends |
| NAD+ (injectable) | Yes | $180/vial |
| NAD+ (nasal spray) | Yes — unique format | Not offered |
| GLP-1 (Sema/Tirze) | Injectable + oral Sema + Tirze | Sema sublingual $200, Tirze $275–$400 |
| TRT | Not a primary offering | $115–$170/mo, oral + injectable |
| Labs Required? | No for most protocols ($0) | 95% no bloodwork required |
| Consultation Fee | Low barrier | Free |
| LegitScript Certified | Yes | — |
| Club Membership | $199/mo direct-to-patient | — |
| Full Review | Read MadeMed Review → | Read Limitless Review → |
MadeMed's oral Sermorelin at $99/month with no lab requirement is currently the lowest-priced Sermorelin option in telehealth, and the oral format removes the injection barrier for many patients. Limitless Alt Med offers injectable Sermorelin at $194 — no labs required — which is a competitive price for injectable, but still higher than MadeMed's oral option. For ongoing monthly Sermorelin therapy, MadeMed wins on cost.
MadeMed also has a unique advantage in NAD+ delivery: nasal spray NAD+ is available alongside injectable, giving patients a non-injection option. Limitless Alt Med offers only injectable NAD+ at $180/vial. However, Limitless pulls ahead with BPC-157 ($325), PT-141 ($184), and GHK-Cu blends — none of which MadeMed currently offers — making Limitless the better choice if injury recovery or sexual performance peptides are goals.
Oral Sermorelin $99/mo (no labs). Injectable Sermorelin $129/mo. Nasal spray NAD+ + injectable NAD+. Oral Sema. LegitScript certified. Club $199/mo.
BPC-157 $325, PT-141 $184, GHK-Cu blends, Sermorelin $194 (no labs), NAD+ $180/vial, TRT $115–$170/mo (oral + injectable). Free consults. Published pricing.
MadeMed wins for Sermorelin-first patients — oral Sermorelin at $99/month with no labs is hard to beat, and the nasal spray NAD+ format is unique in this tier. LegitScript certification and the Club membership add credibility and flexibility.
Limitless Alt Med wins for patients who want BPC-157, PT-141, or TRT alongside their peptide therapy. Free consultations, published pricing across every compound, and oral TRT as an option make it the more complete entry-level peptide clinic for patients with broader protocol goals.
Yes — MadeMed offers oral Sermorelin at $99/month with no lab requirement. Limitless Alt Med offers injectable Sermorelin at $194 (no labs required) but does not have an oral Sermorelin product.
Yes — Limitless Alt Med offers BPC-157 injectable at $325 and PT-141 at $184. MadeMed does not offer BPC-157 or PT-141, making Limitless the better choice for injury recovery and performance peptides.
The MadeMed Club is a $199/month membership providing direct-to-patient pricing on all protocols. It's designed for patients running multiple MadeMed protocols who want access to the full formulary at wholesale rates without per-protocol markups.